Antony Pfaffle, Interim Chief Medical Officer at CorMedix Inc. (CRMD), sold 75,000 shares at $2.58 ($203K) on 2016-05-13, disclosed to the SEC on 2016-05-17.
Open-market sale of $203k CRMD by Interim Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.58 | 20,000 | $52K | 25.4% |
| 2 | $2.68 | 20,000 | $54K | 26.4% |
| 3 | $2.66 | 5,000 | $13K | 6.6% |
| 4 | $2.66 | 5,000 | $13K | 6.6% |
| 5 | $2.83 | 5,000 | $14K | 7.0% |
| 6 | $2.83 | 5,000 |
| $14K |
| 7.0% |
| 7 | $2.84 | 5,000 | $14K | 7.0% |
| 8 | $2.84 | 5,000 | $14K | 7.0% |
| 9 | $2.84 | 5,000 | $14K | 7.0% |
| Total | $2.70 avg | 75,000 | $203K | 100% |
| Filing → |
| CRMD | SELL | 2016-06-22 | $127K | — | Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |